These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
426 related items for PubMed ID: 16125280
1. Tetravalent neutralizing antibody response against four dengue serotypes by a single chimeric dengue envelope antigen. Apt D, Raviprakash K, Brinkman A, Semyonov A, Yang S, Skinner C, Diehl L, Lyons R, Porter K, Punnonen J. Vaccine; 2006 Jan 16; 24(3):335-44. PubMed ID: 16125280 [Abstract] [Full Text] [Related]
2. A chimeric tetravalent dengue DNA vaccine elicits neutralizing antibody to all four virus serotypes in rhesus macaques. Raviprakash K, Apt D, Brinkman A, Skinner C, Yang S, Dawes G, Ewing D, Wu SJ, Bass S, Punnonen J, Porter K. Virology; 2006 Sep 15; 353(1):166-73. PubMed ID: 16814355 [Abstract] [Full Text] [Related]
3. Dengue tetravalent DNA vaccine inducing neutralizing antibody and anamnestic responses to four serotypes in mice. Konishi E, Kosugi S, Imoto J. Vaccine; 2006 Mar 15; 24(12):2200-7. PubMed ID: 16316713 [Abstract] [Full Text] [Related]
12. Carboxy-terminally truncated Dengue 4 virus envelope glycoprotein expressed in Pichia pastoris induced neutralizing antibodies and resistance to Dengue 4 virus challenge in mice. Muné M, Rodríguez R, Ramírez R, Soto Y, Sierra B, Rodríguez Roche R, Marquez G, Garcia J, Guillén G, Guzmán MG. Arch Virol; 2003 Nov 15; 148(11):2267-73. PubMed ID: 14579183 [Abstract] [Full Text] [Related]
13. Pediatric measles vaccine expressing a dengue tetravalent antigen elicits neutralizing antibodies against all four dengue viruses. Brandler S, Ruffie C, Najburg V, Frenkiel MP, Bedouelle H, Desprès P, Tangy F. Vaccine; 2010 Sep 24; 28(41):6730-9. PubMed ID: 20688034 [Abstract] [Full Text] [Related]
14. Induction of neutralizing antibodies and T cell responses by dengue virus type 2 envelope domain III encoded by plasmid and adenoviral vectors. Khanam S, Khanna N, Swaminathan S. Vaccine; 2006 Oct 30; 24(42-43):6513-25. PubMed ID: 16860446 [Abstract] [Full Text] [Related]
15. Evaluation of immunity and protective efficacy of a dengue-3 pre-membrane and envelope DNA vaccine in Aotus nancymae monkeys. Blair PJ, Kochel TJ, Raviprakash K, Guevara C, Salazar M, Wu SJ, Olson JG, Porter KR. Vaccine; 2006 Feb 27; 24(9):1427-32. PubMed ID: 16214271 [Abstract] [Full Text] [Related]
18. Mutational analysis of a neutralization epitope on the dengue type 2 virus (DEN2) envelope protein: monoclonal antibody resistant DEN2/DEN4 chimeras exhibit reduced mouse neurovirulence. Hiramatsu K, Tadano M, Men R, Lai CJ. Virology; 1996 Oct 15; 224(2):437-45. PubMed ID: 8874504 [Abstract] [Full Text] [Related]
20. A tetravalent dengue vaccine containing a mix of domain III-P64k and domain III-capsid proteins induces a protective response in mice. Izquierdo A, García A, Lazo L, Gil L, Marcos E, Alvarez M, Valdés I, Hermida L, Guillén G, Guzmán MG. Arch Virol; 2014 Oct 15; 159(10):2597-604. PubMed ID: 24841761 [Abstract] [Full Text] [Related] Page: [Next] [New Search]